Clinical Trial Results TV
September 29, 2006: Embolic Protection and Thrombectomy: If Yes, When, Who, and How
This video is sponsored by the Duke Clinical Medical Series.

Topics include:
* The Challenge of Vein Graft Intervention: Progress but No Solution
* Slide 12
* Case Presentation
* Case Presentation
* Case Presentation
* Questions
* Saphenous Vein Graft Disease (SVGD)
* Saphenous Vein Graft (SVG) Disease
* Natural History of SVG
* Saphenous Vein Graft (SVG) Disease

The moderator, Peter Berger, MD, has indicated that he receives research/grant support
from Aventis, Conor, Guilford, Lumen, and Velocimed. Dr. Berger is also a member of an
advisory board for Genentech and Cordis/Johnson & Johnson; he has spoken at scientific
symposia for Aventis, Bristol-Myers Squibb, Genentech, and Guilford. Dr. Berger also
serves as Medical Director and has equity with Lumen, Inc.

The guest faculty, James Hermiller, MD, has indicated that he receives research/grant
support from Cordis/Johnson & Johnson, Medtronic, Boston Scientific, and Guidant. In
addition, he is a consultant for Boston Scientific, Guidant, and Abbott.

The fellow, Ing Hann Lim, MD, has indicated that she has nothing to disclose.



Embolic Protection and Thrombectomy: If Yes, When, Who, and How

Please select your viewing options:

Windows Media: 56k 100k
RealPlayer: 56k 100k
Number Viewing:
Need a media player? Please choose one of the free downloads below:
Get Windows Media PlayerDownload RealPlayer

Video Statistics
1 out of 5

1 Star 2 Star 3 Star 4 Star 5 Star

click a star to vote
This submission has received 1 total votes.

These statistics are updated nightly. The last update ran on
10-19-2021 EST at 1 am.

Additional Files
Filename File Description Action
No additional files available

Comments [ login to comment ]
No comments have been submitted